Artivion (AORT) Stock Forecast, Price Target & Predictions
AORT Stock Forecast
Artivion stock forecast is as follows: an average price target of $30.60 (represents a 14.82% upside from AORT’s last price of $26.65) and a rating consensus of 'Buy', based on 4 wall street analysts offering a 1-year stock forecast.
AORT Price Target
AORT Analyst Ratings
Buy
Artivion Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Oct 23, 2024 | Daniel Stauder | JMP Securities | $33.00 | $26.53 | 24.39% | 23.83% |
Aug 09, 2024 | Suraj Kalia | Oppenheimer | $30.00 | $25.33 | 18.44% | 12.57% |
Jul 10, 2024 | Frank Takkinen | Lake Street | $30.00 | $25.94 | 15.65% | 12.57% |
Jul 02, 2024 | Frank Takkinen | Loop Capital Markets | $30.00 | $26.02 | 15.32% | 12.57% |
May 07, 2024 | Mike Matson | Needham | $30.00 | $21.07 | 42.38% | 12.57% |
10
Artivion Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | 1 | 1 | 5 |
Avg Price Target | $33.00 | $33.00 | $30.60 |
Last Closing Price | $26.65 | $26.65 | $26.65 |
Upside/Downside | 23.83% | 23.83% | 14.82% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Oct 23, 2024 | Stifel Nicolaus | Market Outperform | Market Outperform | Hold |
Oct 23, 2024 | Oppenheimer | Underperform | Underperform | Hold |
Oct 23, 2024 | JMP Securities | Market Outperform | Outperform | Initialise |
Oct 23, 2024 | JMP Securities | - | Market Outperform | Initialise |
Sep 27, 2024 | Needham | Buy | Buy | Hold |
Sep 13, 2024 | Stifel Nicolaus | Buy | Buy | Hold |
Aug 09, 2024 | Oppenheimer | Outperform | Outperform | Hold |
Jul 02, 2024 | Needham | Buy | Buy | Hold |
Jul 02, 2024 | Lake Street | Buy | Buy | Hold |
May 07, 2024 | Needham | Buy | Buy | Hold |
10
Artivion Financial Forecast
Artivion Revenue Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $93.67M | $87.85M | $89.25M | $83.23M | $79.40M | $76.84M | $80.34M | $77.21M | $79.39M | $72.21M | $76.15M | $71.09M | $67.90M | $65.13M | $53.77M | $66.43M | $69.70M | $67.88M |
Avg Forecast | $123.85M | $116.51M | $119.61M | $117.24M | $112.07M | $105.71M | $107.83M | $104.65M | $101.15M | $94.76M | $97.60M | $92.06M | $89.28M | $84.32M | $84.24M | $80.35M | $79.85M | $76.19M | $77.28M | $74.85M | $77.77M | $72.40M | $70.97M | $62.97M | $66.53M | $59.23M | $50.46M | $66.00M | $70.82M | $68.29M |
High Forecast | $125.69M | $118.24M | $121.39M | $118.98M | $113.73M | $107.28M | $109.44M | $105.35M | $102.24M | $94.78M | $97.60M | $92.06M | $89.33M | $86.80M | $85.49M | $81.54M | $81.04M | $76.19M | $77.28M | $74.85M | $77.77M | $72.40M | $70.97M | $62.97M | $66.53M | $59.23M | $50.46M | $66.00M | $70.82M | $68.29M |
Low Forecast | $120.68M | $113.53M | $116.55M | $114.24M | $109.20M | $103.01M | $105.07M | $103.95M | $100.06M | $94.74M | $97.60M | $92.06M | $89.23M | $83.00M | $82.08M | $78.29M | $77.81M | $76.19M | $77.28M | $74.85M | $77.77M | $72.40M | $70.97M | $62.97M | $66.53M | $59.23M | $50.46M | $66.00M | $70.82M | $68.29M |
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 4 | 2 | 1 | 1 | 2 | 5 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 3 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.05% | 1.04% | 1.06% | 1.04% | 0.99% | 1.01% | 1.04% | 1.03% | 1.02% | 1.00% | 1.07% | 1.13% | 1.02% | 1.10% | 1.07% | 1.01% | 0.98% | 0.99% |
Forecast
Artivion EBITDA Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 4 | 2 | 1 | 1 | 2 | 5 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 3 |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $3.17M | $-1.24M | $7.67M | $2.91M | $8.65M | $-2.21M | $6.42M | $7.40M | $-6.23M | $18.05M | $8.66M | $5.54M | $10.52M | $5.93M | $3.63M | $151.00K | $10.23M | $7.09M |
Avg Forecast | $11.87M | $11.16M | $11.46M | $11.23M | $10.74M | $10.13M | $10.33M | $10.03M | $9.69M | $9.08M | $9.35M | $8.82M | $8.55M | $8.08M | $8.07M | $7.70M | $7.65M | $4.28M | $4.34M | $14.98M | $-14.77M | $4.06M | $3.98M | $3.53M | $3.73M | $3.32M | $2.83M | $3.70M | $3.97M | $3.83M |
High Forecast | $12.04M | $11.33M | $11.63M | $11.40M | $10.90M | $10.28M | $10.49M | $10.09M | $9.80M | $9.08M | $9.35M | $8.82M | $8.56M | $8.32M | $8.19M | $7.81M | $7.76M | $4.28M | $4.34M | $17.98M | $-11.82M | $4.06M | $3.98M | $3.53M | $3.73M | $3.32M | $2.83M | $3.70M | $3.97M | $3.83M |
Low Forecast | $11.56M | $10.88M | $11.17M | $10.95M | $10.46M | $9.87M | $10.07M | $9.96M | $9.59M | $9.08M | $9.35M | $8.82M | $8.55M | $7.95M | $7.86M | $7.50M | $7.46M | $4.28M | $4.34M | $11.99M | $-17.73M | $4.06M | $3.98M | $3.53M | $3.73M | $3.32M | $2.83M | $3.70M | $3.97M | $3.83M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.37% | -0.15% | 0.95% | 0.38% | 1.13% | -0.52% | 1.48% | 0.49% | 0.42% | 4.44% | 2.18% | 1.57% | 2.82% | 1.79% | 1.28% | 0.04% | 2.57% | 1.85% |
Forecast
Artivion Net Income Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 4 | 2 | 1 | 1 | 2 | 5 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 3 |
Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $-3.98M | $-9.80M | $-3.38M | $-13.53M | $2.17M | $-13.71M | $-4.26M | $-3.39M | $-20.10M | $10.58M | $-2.18M | $-3.14M | $-3.46M | $-2.87M | $-3.69M | $-6.67M | $-681.00K | $-134.00K |
Avg Forecast | $7.31M | $4.74M | $5.30M | $4.54M | $4.77M | $2.03M | $1.89M | $11.72K | $-2.58M | $-2.65M | $-3.77M | $-5.02M | $-3.60M | $-2.59M | $-2.30M | $-4.69M | $-5.19M | $-5.17M | $-3.75M | $-6.86M | $-47.69M | $1.04M | $42.15M | $-3.89M | $-1.88M | $-3.86M | $-7.29M | $1.04M | $1.18M | $694.73K |
High Forecast | $7.45M | $4.83M | $5.40M | $4.63M | $4.86M | $2.07M | $1.93M | $11.94K | $-2.49M | $-2.56M | $-3.64M | $-4.85M | $-3.48M | $432.39K | $-2.22M | $-4.53M | $-5.02M | $-5.17M | $-3.75M | $-5.49M | $-38.15M | $1.04M | $42.15M | $-3.89M | $-1.88M | $-3.86M | $-7.29M | $1.04M | $1.18M | $694.73K |
Low Forecast | $7.06M | $4.59M | $5.12M | $4.39M | $4.61M | $1.96M | $1.83M | $11.33K | $-2.63M | $-2.70M | $-3.84M | $-5.12M | $-3.67M | $-4.32M | $-2.35M | $-4.78M | $-5.29M | $-5.17M | $-3.75M | $-8.24M | $-57.23M | $1.04M | $42.15M | $-3.89M | $-1.88M | $-3.86M | $-7.29M | $1.04M | $1.18M | $694.73K |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.10% | 3.78% | 1.47% | 2.89% | -0.42% | 2.65% | 1.14% | 0.49% | 0.42% | 10.15% | -0.05% | 0.81% | 1.84% | 0.74% | 0.51% | -6.40% | -0.58% | -0.19% |
Forecast
Artivion SG&A Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 4 | 2 | 1 | 1 | 2 | 5 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 3 |
SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $50.28M | $51.09M | $57.24M | $50.37M | $38.45M | $41.05M | $38.98M | $38.95M | $51.25M | $39.05M | $40.83M | $38.64M | $36.10M | $33.74M | $32.29M | $39.00M | $37.61M | $34.26M |
Avg Forecast | $67.75M | $63.74M | $65.44M | $64.14M | $61.31M | $57.83M | $58.99M | $57.25M | $55.34M | $51.84M | $53.39M | $50.36M | $48.84M | $46.13M | $46.08M | $43.95M | $43.68M | $40.02M | $40.59M | $39.32M | $40.85M | $38.03M | $37.28M | $33.08M | $34.95M | $31.11M | $26.51M | $34.67M | $37.20M | $35.87M |
High Forecast | $68.76M | $64.69M | $66.41M | $65.09M | $62.22M | $58.69M | $59.87M | $57.63M | $55.93M | $51.85M | $53.39M | $50.36M | $48.87M | $47.48M | $46.77M | $44.61M | $44.33M | $40.02M | $40.59M | $39.32M | $40.85M | $38.03M | $37.28M | $33.08M | $34.95M | $31.11M | $26.51M | $34.67M | $37.20M | $35.87M |
Low Forecast | $66.02M | $62.11M | $63.76M | $62.49M | $59.74M | $56.35M | $57.48M | $56.87M | $54.74M | $51.83M | $53.39M | $50.36M | $48.81M | $45.41M | $44.90M | $42.83M | $42.56M | $40.02M | $40.59M | $39.32M | $40.85M | $38.03M | $37.28M | $33.08M | $34.95M | $31.11M | $26.51M | $34.67M | $37.20M | $35.87M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.03% | 1.11% | 1.24% | 1.15% | 0.88% | 1.03% | 0.96% | 0.99% | 1.25% | 1.03% | 1.10% | 1.17% | 1.03% | 1.08% | 1.22% | 1.12% | 1.01% | 0.96% |
Forecast
Artivion EPS Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 4 | 2 | 1 | 1 | 2 | 5 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 3 |
EPS | - | - | - | - | - | - | - | - | - | - | - | - | $-0.10 | $-0.24 | $-0.08 | $-0.33 | $0.05 | $-0.34 | $-0.11 | $-0.09 | $-0.51 | $0.27 | $-0.06 | $-0.08 | $-0.09 | $-0.08 | $-0.10 | $-0.18 | $-0.02 | $-0.00 |
Avg Forecast | $0.17 | $0.11 | $0.13 | $0.11 | $0.11 | $0.05 | $0.05 | - | $-0.06 | $-0.06 | $-0.09 | $-0.12 | $-0.09 | $-0.06 | $-0.06 | $-0.11 | $-0.12 | $-0.12 | $-0.09 | $-0.12 | $-0.06 | $0.03 | $1.01 | $-0.09 | $-0.04 | $-0.09 | $-0.17 | $0.03 | $0.03 | $0.02 |
High Forecast | $0.18 | $0.12 | $0.13 | $0.11 | $0.12 | $0.05 | $0.05 | - | $-0.06 | $-0.06 | $-0.09 | $-0.12 | $-0.08 | $0.01 | $-0.05 | $-0.11 | $-0.12 | $-0.12 | $-0.09 | $-0.12 | $-0.06 | $0.03 | $1.01 | $-0.09 | $-0.04 | $-0.09 | $-0.17 | $0.03 | $0.03 | $0.02 |
Low Forecast | $0.17 | $0.11 | $0.12 | $0.10 | $0.11 | $0.05 | $0.04 | - | $-0.06 | $-0.06 | $-0.09 | $-0.12 | $-0.09 | $-0.10 | $-0.06 | $-0.11 | $-0.13 | $-0.12 | $-0.09 | $-0.12 | $-0.06 | $0.03 | $1.01 | $-0.09 | $-0.04 | $-0.09 | $-0.17 | $0.03 | $0.03 | $0.02 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.13% | 3.87% | 1.51% | 2.95% | -0.40% | 2.74% | 1.22% | 0.69% | 8.50% | 10.80% | -0.06% | 0.86% | 2.00% | 0.86% | 0.57% | -7.20% | -0.71% | -0.22% |
Forecast
Artivion Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
SGHT | Sight Sciences | $3.80 | $9.00 | 136.84% | Hold |
ESTA | Establishment Labs | $37.79 | $78.00 | 106.40% | Buy |
LUNG | Pulmonx | $6.34 | $11.93 | 88.17% | Buy |
KIDS | OrthoPediatrics | $22.93 | $39.60 | 72.70% | Buy |
SIBN | SI-BONE | $12.92 | $20.00 | 54.80% | Buy |
NPCE | NeuroPace | $8.98 | $12.88 | 43.43% | Buy |
CNMD | CONMED | $72.24 | $96.00 | 32.89% | Buy |
OFIX | Orthofix Medical | $18.08 | $24.00 | 32.74% | - |
AVNS | Avanos Medical | $18.68 | $23.00 | 23.13% | Hold |
CVRX | CVRx | $13.91 | $16.33 | 17.40% | Buy |
AORT | Artivion | $26.65 | $30.60 | 14.82% | Buy |
ITGR | Integer | $133.18 | $138.00 | 3.62% | Buy |
SRDX | Surmodics | $38.72 | $39.50 | 2.01% | Buy |